SEC Comment Letter for Inhibitor Therapeutics, Inc. (INTI) (CIK 0001042418) (INTI) — Sep 15, 2009

Inhibitor Therapeutics, Inc. (INTI) (CIK 0001042418)
Date: Sept. 15, 2009 · CIK: 0001042418 · Accession: 0000000000-09-051230

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-13467

Date

September 15, 2009

Author

Jeffrey Riedler

Form

UPLOAD

Company

Inhibitor Therapeutics, Inc. (INTI) (CIK 0001042418)

Letter

Mail Stop 4720 September 15, 2009 Richard J. Freer, Ph.D. Chief Operating Officer and Acting Secretary Commonwealth Biotechnologies, Inc. 601 Biotech Drive Richmond, Virginia 23235 Re: Commonwealth Biotechnologies, Inc. Revised Preliminary Proxy Statement on Form PRER14A Filed September 14, 2009 File No. 001-13467

Dear Dr. Freer: We have completed our review of your Revised Preliminary Proxy Statement on Form PRER14A and have no further comments at this time.

S i n c e r e l y , Jeffrey Riedler Assistant Director

Show Raw Text

Mail Stop 4720
September 15, 2009
         Richard J. Freer, Ph.D.  Chief Operating Officer and Acting Secretary  Commonwealth Biotechnologies, Inc.  601 Biotech Drive Richmond, Virginia 23235
Re: Commonwealth Biotechnologies, Inc.
  Revised Preliminary Proxy Statement on Form PRER14A
  Filed September 14, 2009   File No. 001-13467

Dear Dr. Freer:
We have completed our review of your Revised Preliminary Proxy Statement on
Form PRER14A and have no further comments at this time.

     S i n c e r e l y ,
 Jeffrey Riedler
                                                                                                Assistant Director

SecProbe.io